Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Bahl

Showing results (171-180 of 244) with videos related to

Pageof 25
Sort By:
Cancer Causes & Control : CCC|February 22, 2017
The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partnersEileen Sutton, Lucy E Hackshaw-McGeagh, Jonathan Aning, et al.
American Journal of Clinical Oncology|June 6, 2008
Extended survival in women with brain metastases from HER2 overexpressing breast cancerDavid N Church, Ramayana Modgil, Sam Guglani, et al.
Journal of Cancer Research and Therapeutics|October 21, 2009
Reirradiation for progressive brain metastasesAmit Bahl, Milind Kumar, D N Sharma, et al.
Journal of Oncology|May 23, 2018
Evaluation of Reirradiation in Locally Advanced Head and Neck Cancers: Toxicity and Early Clinical OutcomesAmit Bahl, Arun Singh Oinam, Arun Elangovan, et al.
Advances in Therapy|November 27, 2013
Evolution of the treatment paradigm for patients with metastatic castration-resistant prostate cancerZafar Malik, Heather Payne, Jawaher Ansari, et al.
Journal of Experimental Therapeutics & Oncology|January 19, 2019
Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapyAmit Bahl, Arun Elangovan, Chinna Babu Dracham, et al.
Cancer Epidemiology|February 28, 2026
Comparing the national cancer waiting times dataset with other linked electronic health records to measure treatment timeliness: A national cohort study of kidney cancer in EnglandRaghav Varma, Emily Mayne, Marina A Parry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate CancerGary J R Cook, Wai-Lup Wong, Bal Sanghera, et al.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
BMC Health Services Research|July 5, 2018
Physicians' preferences for bone metastases treatments in France, Germany and the United KingdomYi Qian, Jorge Arellano, Francesca Gatta, et al.
Pageof 25

Showing results (171-180 of 244) with videos related to

Sort By:
Pageof 25
Cancer Causes & Control : CCC|February 22, 2017
The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partnersEileen Sutton, Lucy E Hackshaw-McGeagh, Jonathan Aning, et al.
American Journal of Clinical Oncology|June 6, 2008
Extended survival in women with brain metastases from HER2 overexpressing breast cancerDavid N Church, Ramayana Modgil, Sam Guglani, et al.
Journal of Cancer Research and Therapeutics|October 21, 2009
Reirradiation for progressive brain metastasesAmit Bahl, Milind Kumar, D N Sharma, et al.
Journal of Oncology|May 23, 2018
Evaluation of Reirradiation in Locally Advanced Head and Neck Cancers: Toxicity and Early Clinical OutcomesAmit Bahl, Arun Singh Oinam, Arun Elangovan, et al.
Advances in Therapy|November 27, 2013
Evolution of the treatment paradigm for patients with metastatic castration-resistant prostate cancerZafar Malik, Heather Payne, Jawaher Ansari, et al.
Journal of Experimental Therapeutics & Oncology|January 19, 2019
Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapyAmit Bahl, Arun Elangovan, Chinna Babu Dracham, et al.
Cancer Epidemiology|February 28, 2026
Comparing the national cancer waiting times dataset with other linked electronic health records to measure treatment timeliness: A national cohort study of kidney cancer in EnglandRaghav Varma, Emily Mayne, Marina A Parry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate CancerGary J R Cook, Wai-Lup Wong, Bal Sanghera, et al.
Molecular and Clinical Oncology|July 24, 2014
Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational studyVito Lorusso, Ignacio Duran, Cristina Garzon-Rodriguez, et al.
BMC Health Services Research|July 5, 2018
Physicians' preferences for bone metastases treatments in France, Germany and the United KingdomYi Qian, Jorge Arellano, Francesca Gatta, et al.
Pageof 25